S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AQST Aquestive Therapeutics Inc

3.70

0.06 (1.65%)

Last Updated: 04:19:35

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Aquestive Therapeutics Charts.

Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Aquestive Therapeutics Charts.

Aquestive Therapeutics Inc News

Form 8-K - Current report
Friday 20 December 2024 (1 day ago) • Edgar (US Regulatory)

Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five
Friday 20 December 2024 (1 day ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 3 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual Film
Tuesday 3 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 28 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
Wednesday 13 November 2024 (1 month ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 9 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 5 November 2024 (2 months ago) • Edgar (US Regulatory)

Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Tuesday 5 November 2024 (2 months ago) • GlobeNewswire Inc.

More Aquestive Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions